Johnson & Johnson Newsroom

Johnson & Johnson's (NYSE:JNJ) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Yahoo Finance25minutes ago

With Johnson & Johnson (NYSE:JNJ) It Looks Like You'll Get What You Pay For

Simply Wall StNov 9 20:34

Express News | Johnson & Johnson Submits Applications in the U.S. and EU Seeking Approval of Darzalex Faspro® / Darzalex® as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma

BreakingsNov 8 20:00

Express News | shanghai Municipal Medical Insurance Bureau organizes centralized procurement of pharmaceuticals and high-value consumables exceeding 2 billion yuan

BreakingsNov 8 09:35

J&J Wins Approval of Varipulse Atrial Fibrillation Device

Seeking AlphaNov 8 01:48

Industry Comparison: Evaluating Johnson & Johnson Against Competitors In Pharmaceuticals Industry

BenzingaNov 7 23:00

Band-Aid, Tylenol Parent's Sales Miss the Mark Amid Weakness in Skin Health

MarketWatchNov 7 21:49

Express News | Johnson & Johnson Medtech Receives FDA Approval for Varipulse™ Pulsed Field Ablation Platform for Treatment of Atrial Fibrillation

BreakingsNov 7 21:01

SA Asks: How Will the U.S. Election Results Impact Healthcare Stocks?

Seeking AlphaNov 7 04:17

Johnson & Johnson Analyst Ratings

BenzingaNov 7 02:10 · Ratings

Why Most Healthcare Stocks Are Falling With Trump's Win, With Some Exceptions

MarketWatchNov 7 00:44

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields

BenzingaNov 6 21:39

Guggenheim Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Cuts Target Price to $162

Futu NewsNov 6 21:31 · Ratings

Guggenheim Adjusts Johnson & Johnson's Price Target to $162 From $156, Keeps Neutral Rating

MT NewswiresNov 6 19:25 · Ratings

Express News | Global first BCMA x CD3 bispecific drug Tlachol is launched in China.

BreakingsNov 6 16:59

Johnson & Johnson (JNJ.US) monoclonal antibody therapy achieves Phase 3 clinical primary endpoints significantly delaying high-risk SMM progression.

The American Society of Hematology (ASH) released abstracts of some studies at its 2024 conference.

Zhitong FinanceNov 6 15:26

Johnson & Johnson Darzalex Shows Efficacy in Early-stage Multiple Myeloma

Seeking AlphaNov 6 02:50

AI Robot Trader Dumped Microsoft, Amazon Stocks and Went Defensive. Here's What It Bought. -- Barrons.com

Barron'sNov 5 23:33

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Nov 5 21:10

With 73% Ownership of the Shares, Johnson & Johnson (NYSE:JNJ) Is Heavily Dominated by Institutional Owners

Yahoo FinanceNov 5 19:00